Concentrated Omega-3 (rTG form)
Re-esterified triglyceride omega-3 is absorbed better than the cheap ethyl ester form, so a given labelled dose raises blood levels more. The difference is real but modest, and total EPA plus DHA intake still matters far more than the form.
What the science says
- Absorbed better than ethyl esters Moderate evidence
In a two-week comparison in healthy adults, relative bioavailability of EPA plus DHA measured by change in the omega-3 index was about 73% for ethyl esters and about 124% for re-esterified triglycerides, using natural fish oil triglycerides as the 100% reference. The gap is widest when capsules are taken without a fat-containing meal, since ethyl esters depend heavily on pancreatic lipase activity.
- Produces a better clinical effect on triglycerides Limited evidence
In a six-month randomised trial in statin-treated dyslipidemic patients, moderate doses of EPA and DHA as re-esterified triacylglycerols lowered fasting serum triglycerides while the same dose as ethyl esters did not. That is one trial, and high-dose prescription ethyl ester products lower triglycerides reliably in large trials, so the practical message is that form determines how much you need, not whether omega-3 works.
- All products labelled rTG are equivalent Limited evidence
They are not. A 16-week randomised trial found a product that was more than 95% rTG raised erythrocyte EPA, DPA and DHA more than a product under 70% rTG at similar labelled EPA plus DHA doses. Re-esterification is incomplete in many commercial oils, and the percentage is almost never disclosed. Note this trial was conducted by researchers affiliated with one of the manufacturers.
- Concentration itself is useful Moderate evidence
Concentrated oils deliver roughly 500-900 mg of EPA plus DHA per 1 g capsule versus about 300 mg for standard fish oil, so hitting 2 g/day takes 2-4 capsules instead of 6-7. Fewer capsules means less non-omega-3 fat, less oxidisable oil ingested, and better adherence, which is the most common reason supplementation fails.
Dosage & safety
How to take it
Interactions
With medications
- warfarin, DOACs and antiplatelet drugs
Doses of 3 g/day or more modestly prolong bleeding time; clinically significant bleeding is uncommon but the combination deserves a conversation. stay at or below 1 g/day unless your prescriber agrees, and mention it before surgery
- prescription omega-3 (icosapent ethyl, omega-3-acid ethyl esters)
A supplement on top duplicates the same active fatty acids. do not stack them
With other supplements
- fish oil, krill oil or algal DHA products
They all count toward the same EPA+DHA total, and 4 g/day has been linked to more atrial fibrillation. add up EPA+DHA across everything rather than counting capsules
Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.
Frequently asked questions
Is rTG omega-3 better absorbed than ethyl ester fish oil?
Yes, with moderate evidence: in one comparison, re-esterified triglyceride (rTG) omega-3 had about 124% relative bioavailability versus about 73% for ethyl esters. The gap is widest when capsules are taken without a fat-containing meal, and total EPA plus DHA still matters more than the form.
Are all rTG omega-3 products the same?
No. Re-esterification is incomplete in many commercial rTG oils, and one trial found a product that was more than 95% rTG raised blood omega-3 more than one under 70% rTG, though that trial was manufacturer-affiliated. The rTG percentage is almost never disclosed.
How much omega-3 should I take per day?
Whatever the form, including rTG omega-3, take 250-500 mg/day of combined EPA plus DHA for general maintenance, or 1-2 g/day for triglyceride reduction; 2-4 g/day should be medically supervised. Read the EPA plus DHA line, not the fish oil weight, and take it with a fat-containing meal.
Is high-dose omega-3 safe with blood thinners?
Omega-3 at 3 g/day or more modestly prolongs bleeding time, so if you take warfarin, a DOAC or antiplatelet drugs, stay at or below 1 g/day unless your prescriber agrees. Large trials also found more atrial fibrillation at 4 g/day.
Scientific references
- Bioavailability of marine n-3 fatty acid formulations
- Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial
- Comparative membrane incorporation of omega-3 fish oil triglyceride preparations differing by degree of re-esterification: A sixteen-week randomized intervention trial
Where to buy
Sports Research, Omega-3 Fish Oil, 180 Softgels
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
Related in Heart & metabolic
- Vitamin B3 (Niacin) Limited evidence
- Vitamin K2 (MK-7) Limited evidence
- Chromium Limited evidence
- Potassium Strong evidence
- Vanadium Limited evidence
- L-Arginine Moderate evidence